Back to Search Start Over

Novel VPS13A Gene Mutations Identified in Patients Diagnosed with Chorea-acanthocytosis (ChAc): Case Presentation and Literature Review.

Authors :
Shen Y
Liu X
Long X
Han C
Wan F
Fan W
Guo X
Ma K
Guo S
Wang L
Xia Y
Liu L
Huang J
Lin Z
Xiong N
Wang T
Source :
Frontiers in aging neuroscience [Front Aging Neurosci] 2017 Apr 12; Vol. 9, pp. 95. Date of Electronic Publication: 2017 Apr 12 (Print Publication: 2017).
Publication Year :
2017

Abstract

Chorea-acanthocytosis (ChAc) is a rare autosomal recessive inherited syndrome characterized by hyperkinetic movements, seizures, cognitive impairment, neuropsychiatric symptoms, elevated serum biochemical indicators and acanthocytes detection in peripheral blood smear. Vacuolar protein sorting 13A (VPS13A) gene mutations have been proven to be genetically responsible for the pathogenesis of ChAc. Herein, based on the typical clinical symptoms and neuroimaging features, we present two suspected ChAc cases which are further genetically confirmed by four novel VPS13A gene mutations. Nevertheless, the sharp contrast between the population base and published ChAc reports implies that ChAc is considerably underdiagnosed in China. Therefore, we conclude several suggestive features and propose a diagnostic path of ChAc from a clinical, genetic and neuroimaging perspective, aiming to facilitate the diagnosis and management of ChAc in China.

Details

Language :
English
ISSN :
1663-4365
Volume :
9
Database :
MEDLINE
Journal :
Frontiers in aging neuroscience
Publication Type :
Academic Journal
Accession number :
28446873
Full Text :
https://doi.org/10.3389/fnagi.2017.00095